Binding triggers intracellular calcium mobilization and cAMP elevation, which releases GH stored in secretory granules
Important context: SURMOUNT-5 was an open-label trial funded by Eli Lilly, the manufacturer of tirzepatide
Obstructive Sleep Apnea Obstructive sleep apnea is a parallel Phase 3 indication
"With the positive results across five Phase 3 studies, we now have the clinical data package to support global submissions for retatrutide and look forward to working with regulators as they evaluate this first-of-its-kind medicine, said Kenneth Custer, Ph.D., executive vice president and president, Lilly Cardiometabolic Health
The 2026 evidence says comparable testosterone against gel, worse against injections, and a possible cost in sexual function
Professional Communications Inc